Related Experiment Video

Updated: Mar 7, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K

Retrospective evaluation of a national guideline to prevent neonatal hypoglycemia

Annett Helleskov Rasmussen1, Sonja Wehberg2, Jesper Fenger-Groen3

  • 1Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

Pediatrics and Neonatology
|February 27, 2017
PubMed

Insights

A new national guideline stratified neonatal hypoglycemia risk, leading to a significant decrease in hypoglycemia incidence among at-risk newborns. Further prospective studies are needed to confirm causality.

Area of Science:

  • Neonatal Medicine
  • Public Health
  • Clinical Guidelines

Background:

  • Neonatal hypoglycemia is common and can lead to adverse neurological outcomes.
  • Current guidelines for preventing hypoglycemia are not stratified by risk severity, potentially causing inefficient interventions.
  • This study evaluated a national prevention guideline stratified by mild, moderate, and severe hypoglycemia risks.

Purpose of the Study:

  • To assess the impact of a national hypoglycemia prevention guideline stratified by risk severity on neonatal hypoglycemia incidence.
  • To determine if risk stratification in guidelines improves prevention of neonatal hypoglycemia.

Main Methods:

  • Retrospective cohort study of 22,725 neonates using national registers before and after guideline implementation.
  • Identified neonates with hypoglycemia diagnoses and recorded risk factors (SGA, LGA, asphyxia, prematurity, maternal diabetes).
  • Validated hypoglycemia diagnoses and calculated adjusted odds ratios (aORs) to assess guideline impact.

Main Results:

  • Overall hypoglycemia incidence decreased from 9.4% to 5.5% post-guideline implementation.
  • Validated hypoglycemia incidence dropped from 2.1% to 1.2%.
  • Significant reductions in hypoglycemia incidence were observed in small for gestational age (SGA), preterm, and asphyxia risk groups.

Conclusions:

  • Stratification of hypoglycemia risk in a national guideline was associated with a decreased incidence of neonatal hypoglycemia.
  • While results are promising, no definitive causative conclusion can be drawn.
  • Prospective studies are recommended to further investigate risk-stratified hypoglycemia prevention.
Abstract

Keywords:
hypoglycemianeonateprevention

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.2K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615